AVENIR CORP 13D and 13G filings for Cytosorbents Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 10:22 am Purchase |
2024-12-31 | 13G | Cytosorbents Corporation CTSO |
AVENIR CORP | 3,093,946 5.700% |
42,544 (+1.39%) |
Filing |
| 2024-02-14 4:42 pm Purchase |
2023-12-31 | 13G | Cytosorbents Corporation CTSO |
AVENIR CORP | 3,051,402 6.870% |
604,313 (+24.70%) |
Filing |
| 2023-02-14 1:08 pm Purchase |
2022-12-31 | 13G | Cytosorbents Corporation CTSO |
AVENIR CORP | 2,447,089 5.610% |
259,307 (+11.85%) |
Filing |
| 2022-08-11 08:39 am Purchase |
2022-07-26 | 13G | Cytosorbents Corporation CTSO |
AVENIR CORP | 2,187,782 5.020% |
30,949 (+1.43%) |
Filing |
| 2022-06-27 5:34 pm Sale |
2022-05-26 | 13G | Cytosorbents Corporation CTSO |
AVENIR CORP | 2,156,833 4.950% |
-20,313 (-0.93%) |
Filing |
| 2022-04-22 5:34 pm Purchase |
2022-03-22 | 13G | Cytosorbents Corporation CTSO |
AVENIR CORP | 2,177,146 5.000% |
89,075 (+4.27%) |
Filing |
| 2022-01-07 5:10 pm Sale |
2021-12-20 | 13G | Cytosorbents Corporation CTSO |
AVENIR CORP | 2,088,071 4.800% |
-156,264 (-6.96%) |
Filing |
| 2021-12-13 5:01 pm Purchase |
2021-11-16 | 13G | Cytosorbents Corporation CTSO |
AVENIR CORP | 2,244,335 5.160% |
2,244,335 (New Position) |
Filing |